Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 51.98% is in line with its 5-year average of 48.45%, around the middle of its 5-year range (43.21%–56.38%).
As of the fiscal period ended Tuesday, June 30, 2026. 0.09% above its 12-month average of 51.93%.
Reported quarterly gross margin; no daily interpolation.
GROSS MARGIN
51.98%
GROSS MARGIN AVG TTM
51.93%
GROSS MARGIN AVG 3Y
49.57%
GROSS MARGIN AVG 5Y
48.45%
GROSS MARGIN AVG 10Y
47.41%
GROSS MARGIN AVG 15Y
49.92%
GROSS MARGIN AVG 20Y
50.80%
CURRENT VS TTM AVG
+0.09%
CURRENT VS 3Y AVG
+4.86%
CURRENT VS 5Y AVG
+7.28%
CURRENT VS 10Y AVG
+9.63%
CURRENT VS 15Y AVG
+4.13%
CURRENT VS 20Y AVG
+2.32%
SECTOR MEDIAN · HEALTHCARE
60.23%
median of 88 covered companies
CURRENT VS SECTOR MEDIAN
-13.70%
vs the sector median at left
Teva Pharmaceutical Industries Limited
Market Cap
$42.82B
Gross Margin
51.98%
TTM Avg
51.93%
3Y Avg
49.57%
5Y Avg
48.45%
Market Cap
$43.10B
Gross Margin
26.23%
TTM Avg
30.59%
3Y Avg
32.75%
5Y Avg
33.07%
Market Cap
$43.39B
Gross Margin
53.73%
TTM Avg
53.36%
3Y Avg
52.95%
5Y Avg
53.14%
Market Cap
$43.62B
Gross Margin
62.45%
TTM Avg
61.42%
3Y Avg
60.55%
5Y Avg
59.83%
Market Cap
$51.97B
Gross Margin
77.98%
TTM Avg
78.79%
3Y Avg
78.80%
5Y Avg
77.78%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Teva Pharmaceutical Industries Limited (TEVA) | $42.82B | 51.98% | 51.93% | 49.57% | 48.45% |
| IQVIA Holdings Inc. (IQV)vs › | $43.10B | 26.23% | 30.59% | 32.75% | 33.07% |
| Agilent Technologies, Inc. (A)vs › | $43.39B | 53.73% | 53.36% | 52.95% | 53.14% |
| IDEXX Laboratories, Inc. (IDXX)vs › | $43.62B | 62.45% | 61.42% | 60.55% | 59.83% |
| Humana Inc. (HUM)vs › | $46.95B | 13.65% | 14.54% | 16.14% | 17.03% |
| Alcon Inc. (ALC)vs › | $34.95B | 56.43% | 55.42% | 55.20% | 53.33% |
| ResMed Inc. (RMD)vs › | $34.73B | 61.16% | 60.26% | 58.24% | 57.85% |
| DexCom, Inc. (DXCM)vs › | $34.14B | 62.47% | 60.28% | 62.12% | 63.92% |
| Edwards Lifesciences Corporation (EW)vs › | $51.97B | 77.98% | 78.79% | 78.80% | 77.78% |
| Becton, Dickinson and Company (BDX)vs › | $52.22B | 46.12% | 45.33% | 44.44% | 44.19% |
Gross Margin
52.0%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 51.98% |
| 2026-03-31 | 49.54% |
| 2025-12-31 | 56.38% |
| 2025-09-30 | 51.43% |
| 2025-06-30 | 50.34% |
| 2025-03-31 | 48.24% |
| 2024-12-31 | 50.13% |
| 2024-09-30 | 49.60% |
| 2024-06-30 | 48.61% |
| 2024-03-31 | 46.37% |
| 2023-12-31 | 54.21% |
| 2023-09-30 | 48.08% |
| 2023-06-30 | 46.31% |
| 2023-03-31 | 43.21% |
| 2022-12-31 | 45.58% |
| 2022-09-30 | 46.43% |
| 2022-06-30 | 47.39% |
| 2022-03-31 | 47.53% |
| 2021-12-31 | 50.00% |
| 2021-09-30 | 46.15% |
| 2021-06-30 | 47.90% |
| 2021-03-31 | 47.16% |
| 2020-12-31 | 45.99% |
| 2020-09-30 | 46.56% |
| 2020-06-30 | 45.56% |
| 2020-03-31 | 47.35% |
| 2019-12-31 | 43.81% |
| 2019-09-30 | 42.89% |
| 2019-06-30 | 43.67% |
| 2019-03-31 | 43.19% |
| 2018-12-31 | 43.23% |
| 2018-09-30 | 44.62% |
| 2018-06-30 | 43.84% |
| 2018-03-31 | 46.36% |
| 2017-12-31 | 46.57% |
| 2017-09-30 | 47.11% |
| 2017-06-30 | 49.61% |
| 2017-03-31 | 50.07% |
| 2016-12-31 | 52.22% |
| 2016-09-30 | 50.35% |
| 2016-06-30 | 57.11% |
| 2016-03-31 | 58.02% |
| 2015-12-31 | 58.33% |
| 2015-09-30 | 57.45% |
| 2015-06-30 | 58.44% |
| 2015-03-31 | 56.92% |
| 2014-12-31 | 55.90% |
| 2014-09-30 | 55.54% |
| 2014-06-30 | 52.75% |
| 2014-03-31 | 53.93% |
| 2013-12-31 | 53.30% |
| 2013-09-30 | 51.99% |
| 2013-06-30 | 52.66% |
| 2013-03-31 | 52.85% |
| 2012-12-31 | 53.06% |
| 2012-09-30 | 52.31% |
| 2012-06-30 | 53.20% |
| 2012-03-31 | 51.14% |
| 2011-12-31 | 50.76% |
| 2011-09-30 | 51.70% |
| 2011-06-30 | 52.23% |
| 2011-03-31 | 53.63% |
| 2010-12-31 | 55.77% |
| 2010-09-30 | 58.05% |
| 2010-06-30 | 55.82% |
| 2010-03-31 | 55.11% |
| 2009-12-31 | 55.21% |
| 2009-09-30 | 54.31% |
| 2009-06-30 | 52.03% |
| 2009-03-31 | 49.92% |
| 2008-12-31 | 56.14% |
| 2008-09-30 | 52.50% |
| 2008-06-30 | 53.31% |
| 2008-03-31 | 53.34% |
| 2007-12-31 | 52.29% |
| 2007-09-30 | 52.83% |
| 2007-06-30 | 52.10% |
| 2007-03-31 | 49.86% |
| 2006-12-31 | 48.41% |
| 2006-09-30 | 55.20% |
| 2006-06-30 | 53.92% |
| 2006-03-31 | 43.25% |
| 2005-12-31 | 48.29% |
| 2005-09-30 | 46.96% |
| 2005-06-30 | 47.41% |
| 2005-03-31 | 46.26% |
| 2004-12-31 | 46.57% |
| 2004-09-30 | 47.27% |
| 2004-06-30 | 47.03% |
| 2004-03-31 | 45.65% |
| 2003-12-31 | 45.97% |
| 2003-09-30 | 46.42% |
| 2003-06-30 | 47.14% |
| 2003-03-31 | 46.00% |
| 2002-12-31 | 44.04% |
| 2002-09-30 | 42.86% |
